S-309721

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameS-309721

Drug Alias NameS-30972-1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA topoisomerase inhibitors

TargetsDNA topoisomerase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumFrance

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A